Cibus Inc (CBUS) USD0.0001 A

Sell:$2.26Buy:$3.33$0.05 (2.02%)

Prices delayed by at least 15 minutes
Sell:$2.26
Buy:$3.33
Change:$0.05 (2.02%)
Prices delayed by at least 15 minutes
Sell:$2.26
Buy:$3.33
Change:$0.05 (2.02%)
Prices delayed by at least 15 minutes

Company Information

About this company

Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.

Key people

Rory B. Riggs
Chairman of the Board, Chief Executive Officer, Co-Founder
Peter Ronald Beetham
President, Co-Founder, Chief Operating Officer, Director
Greg Gocal
Co-Founder, Executive Vice President, Chief Scientific Officer
Carlo Broos
Interim Chief Financial Officer
Mark Finn
Lead Independent Director
August J. Moretti
Director
Jean-Pierre Lehmann
Independent Director
Gerhard Prante
Independent Director
Keith A. Walker
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US17166A1016
  • Market cap
    $83.69m
  • Employees
    183
  • Shares in issue
    31.21m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.